Product Candidates
Acura Development Pipeline
Immediate Release Tablet Candidates

Pfizer, Inc. has licenses in the U.S., Canada, and Mexico to the Aversion Technology for use in 4 opioids.
Oxecta® is a trademark of Pfizer Inc.
*Human clinical testing is permitted under an IND or equivalent filing, or pursuant to regulation.

